ONLINE DATABASE SEARCH -
OI-LS-376-MEMO
1.
61036 OI-LS-376;
WOS-OI-6/1/2007
Antiviral and Antimicrobial Profiles of Selected Isoquinoline Alkaloids
From Fumaria and Corydalis Species
Orhan, I. et al.
Zeitschrift Fur Naturforschung C-a Journal of Biosciences
2007. 62(1-2):
19-26
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245739200004
2.
61037 OI-LS-376;
EMBASE-OI-6/11/2007
Oxadiazole mannich bases: Synthesis and antimycobacterial
activity
Ali, Mohamed Ashraf and Shaharyar, Mohammad
Bioorganic & Medicinal Chemistry Letters 2007. 17(12): 3314-3316
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4NF4F18-4/2/4dcb3d555c1a666ffdb8889aa9ab3b45
3.
61038 OI-LS-376;
EMBASE-OI-6/11/2007
Synthesis of Symmetrical C- and Pseudo-symmetrical O-Linked Disaccharide
Analogs for Arabinosyltransferase Inhibitory Activity in Mycobacterium
tuberculosis
Pathak, Ashish K, Pathak, Vibha, Riordan, James R, Suling, William J,
Gurcha, Sudagar S, Besra, Gurdyal S, and Reynolds, Robert
C
Bioorganic & Medicinal Chemistry Letters 2007. In Press, Accepted Manuscript:
748
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4NX2NGR-2/2/5a46bc1bd398300fa41646dafffa5818
4.
61039 OI-LS-376;
EMBASE-OI-6/11/2007
Ligand based virtual screening and biological evaluation of inhibitors of
chorismate mutase (Rv1885c) from Mycobacterium tuberculosis
H37Rv
Agrawal, Himanshu, Kumar, Ashutosh, Bal, Naresh Chandra, Siddiqi,
Mohammad Imran, and Arora, Ashish
Bioorganic & Medicinal Chemistry Letters 2007. 17(11): 3053-3058
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4N9P4JN-1/2/9394e0f02abecadfebb9ec89b64ab95c
5.
61040 OI-LS-376;
EMBASE-OI-6/11/2007
Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with
inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium
tuberculosis
Bonnac, Laurent, Gao, Guang-Yao, Chen, Liqiang, Felczak, Krzysztof,
Bennett, Eric M, Xu, Hua, Kim, TaeSoo, Liu, Nina, Oh, HyeWon, Tonge, Peter J,
and Pankiewicz, Krzysztof W
Bioorganic & Medicinal Chemistry Letters 2007. In Press, Corrected Proof: 727
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4NVT9ST-4/2/9ac22e7762a9507523270f3dfe3b1c92
6.
61041 OI-LS-376;
WOS-OI-6/1/2007
Antimycobacterial Activity From Cyanobacterial Extracts and Phytochemical
Screening of Methanol Extract of Hapalosiphon
Rao, M. et al.
Pharmaceutical Biology 2007.
45(2): 88-93
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245677200002
7.
61042 OI-LS-376;
EMBASE-OI-6/11/2007
Crystallographic studies on the binding of isonicotinyl-NAD adduct to
wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from
Mycobacterium tuberculosis
Dias, Marcio Vinicius Bertacine, Vasconcelos, Igor Bordin, Prado, Adriane
Michele Xavier, Fadel, Valmir, Basso, Luiz Augusto, de Azevedo Jr, Walter
Filgueira, and Santos, Diogenes Santiago
Journal of Structural Biology 2007. In Press, Uncorrected Proof:
205
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WM5-4NMWRBG-1/2/4bd6bd062be8d6e1517d720d8c5cb4f4
8.
61043 OI-LS-376;
EMBASE-OI-6/11/2007
Newer tetracycline derivatives: Synthesis, anti-HIV, antimycobacterial
activities and inhibition of HIV-1 integrase
Sriram, Dharmarajan, Yogeeswari, Perumal, Senchani, Geetha, and Banerjee,
Debjani
Bioorganic & Medicinal Chemistry Letters 2007. 17(8): 2372-2375
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4MCMWJ9-1/2/cee6aa86925226a9541d49894620c43a
9.
61044 OI-LS-376;
WOS-OI-6/1/2007
Superinfection Exclusion in Cells Infected With Hepatitis C
Virus
Tscherne, D. et al.
Journal of Virology 2007.
81(8): 3693-3703
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245692900003
10.
61045 OI-LS-376;
WOS-OI-6/1/2007
New Natural Intergenotypic (2/5) Recombinant of Hepatitis C
Virus
Legrand-Abravanel, F. et al.
Journal of Virology 2007.
81(8): 4357-4362
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245692900068
11.
61046 OI-LS-376;
EMBASE-OI-6/11/2007
Parameters determining the relative efficacy of hydroxy-naphthoquinone
inhibitors of the cytochrome bc1 complex
Kessl, Jacques J, Moskalev, Nikolai V, Gribble, Gordon W, Nasr, Mohamed,
Meshnick, Steven R, and Trumpower, Bernard L
Biochimica et Biophysica Acta (BBA) - Bioenergetics 2007. 1767(4): 319-326
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T1S-4N4YMMW-1/2/06b9aa82b32b24e76a8037a02efb1a05
12.
61047 OI-LS-376;
WOS-OI-6/1/2007
Antimicrobial Activity of Marine Sponges From Uraba Gulf, Colombian
Caribbean Region
Galeano, E. and Martinez, A.
Journal De Mycologie Medicale 2007. 17(1): 21-24
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245772400004
13.
61048 OI-LS-376;
EMBASE-OI-6/11/2007
Synthesis, characterization and antimicrobial activity of new aliphatic
sulfonamide
Ozbek,
Neslihan, Katircioglu, Hikmet, Karacan, Nurcan, and Baykal,
Tulay
Bioorganic & Medicinal Chemistry 2007. 15(15): 5105-5109
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4NS2GDD-5/2/ebeffa42266afe22d2de28d486c8af81
14.
61049 OI-LS-376;
EMBASE-OI-6/11/2007
Design, synthesis and molecular docking studies of novel triazole
antifungal compounds
He, Qiu Qin, Li, Ke, Cao, Yong Bing, Dong, Huan Wen, Zhao, Li Hua, Liu,
Chao Mei, and Sheng, Chun Quan
Chinese Chemical Letters 2007. 18(6): 663-666
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B8G3X-4NVK227-3/2/7b977b09ded38b5bab211645261dcf1b
15.
61050 OI-LS-376;
EMBASE-OI-6/11/2007
Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping
groups on inhibitory potency and pharmacokinetics
Perni, Robert B, Chandorkar, Gurudatt, Cottrell, Kevin M, Gates, Cynthia
A, Lin, Chao, Lin, Kai, Luong, Yu-Ping, Maxwell, John P, Murcko, Mark A, Pitlik,
Janos, Rao, Govinda, Schairer, Wayne C, Drie, John Van, and Wei,
Yunyi
Bioorganic & Medicinal Chemistry Letters 2007. 17(12): 3406-3411
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4NDDM03-1/2/7fbe660613e02d9dc3d24884ff9e8aa7
16.
61051 OI-LS-376;
WOS-OI-6/1/2007
Update 2006/2007 - Treatment of Hepatitis
Anon
Drugs of the Future 2007.
32(2): 187-190
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245698900010
17.
61052 OI-LS-376;
WOS-OI-6/1/2007
Drugs Under Development for the Treatment of Hepatitis
Mealy, N., Lupone, B., and Tell, M.
Drugs of the Future 2007.
32(2): 191-200
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245698900011
18.
61053 OI-LS-376;
WOS-OI-6/1/2007
Drugs From Academia
Borman, S.
Chemical & Engineering News 2007. 85(16): 42-47
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245737800046
19.
61054 OI-LS-376;
WOS-OI-6/1/2007
Relationship Between Mycobacterium Avium Subspecies Paratuberculosis,
Il-1 Alpha, and Traf1 in Primary Bovine Monocyte-Derived
Macrophages
Chiang, S. et al.
Veterinary Immunology and Immunopathology 2007. 116(3-4 ): 131-144
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245797600002
20.
61055 OI-LS-376;
WOS-OI-6/1/2007
Predicting Hcv Treatment Duration With an Hcv Protease Inhibitor
Co-Administered With Peg-Ifn/Rbv by Modeling Both Wild-Type Virus and Low Level
Resistant Variant Dynamics
Khunvichai, A. et al.
Gastroenterology 2007.
132(4): A740-A741
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245927606139
21.
61056 OI-LS-376;
WOS-OI-6/8/2007
Inhibition of Hepatitis C Virus Replication and Expression by Small
Interfering Rna Targeting Host Cellular Genes
Xue, Q. et al.
Journal of Hepatology 2007.
46: S151
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100390
22.
61057 OI-LS-376;
WOS-OI-6/8/2007
Ribavirin Acts as Hepatitis C Virus Mutagen on Nonstructural 5b
Quasispecies in Vitro and During Antiviral Therapy
Hofmann,
W. et al.
Journal of Hepatology 2007.
46: S164
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100429
23.
61058 OI-LS-376;
WOS-OI-6/8/2007
Favorable Cross-Resistance Profile of Two 432 Novel Hepatitis C Virus
Inhibitors, Sch-503034 and Hcv-766, and Enhanced Anti-Replicon Activity Mediated
by the Combined Use of Both Compounds
Howe, A. et al.
Journal of Hepatology 2007.
46: S165
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100431
24.
61059 OI-LS-376;
WOS-OI-6/8/2007
Combinations of 2'-Methylcytidine Analogs With Interferon Alpha-2b Lead
to Synergistic Inhibition of Hepatitis C Virus Replication in a Replicon
System
Bassit, L. et al.
Journal of Hepatology 2007.
46: S217
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100570
25.
61060 OI-LS-376;
WOS-OI-6/8/2007
Ketoprofen Plus Peg-Ifn Alpha-2a and Ribavirin as a Triple Treatment for
Genotype 1 (G1) Chronic Hepatitis C (Chc): Results of a Phase Ii Randomized
Controlled Trial
Gramenzi, A. et al.
Journal of Hepatology 2007.
46: S231
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100610
26.
61061 OI-LS-376;
WOS-OI-6/8/2007
R1479, a Novel Hepatitis C Polymerase Inhibitor: Lack of Pre-Existing
Resistance Mutation Supports the Observed in Vivo High Barrier to
Resistance
Le Pogam, S. et al.
Journal of Hepatology 2007.
46: S235
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100620
27.
61062 OI-LS-376;
WOS-OI-6/8/2007
Novel Mode of Viral Decline During Telaprevir (Vx-950) and Peg-Ifn
Combination Treatment Predicted by a New Combined Intracellular and Cellular
Hepatitis C Viral Dynamics Model
Neumann, A. et al.
Journal of Hepatology 2007.
46: S236
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100623
28.
61063 OI-LS-376;
WOS-OI-6/8/2007
The Influence of Nucleoside Free Haart on the Treatment of Chronic
Hepatitis C With Pegylated Interferon/Ribavirin Combination
Treatment
Rockstroh, J. et
al.
Journal of Hepatology 2007.
46: S240
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100633
29.
61064 OI-LS-376;
WOS-OI-6/8/2007
Combination of Two Hepatitis C Virus Inhibitors, Sch 503034 and Nm107,
Provides Enhanced Antireplicon Activity and Suppresses Emergence of Resistant
Replicons
Ralston, R. et al.
Journal of Hepatology 2007.
46: S298-S299
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100788
30.
61065 OI-LS-376;
WOS-OI-6/8/2007
Purines
Bearing Phenanthroline or Bipyridine Ligands and Their Ru-Ii Complexes in
Position 8 as Model Compounds for Electrochemical Dna Labeling - Synthesis,
Crystal Structure, Electrochemistry, Quantum Chemical Calculations, Cytostatic
and Antiviral Activity
Vrabel, M. et al.
European Journal of Inorganic Chemistry 2007.(12):
1752-1769
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246404900016
31.
61066 OI-LS-376;
WOS-OI-6/8/2007
Inhibitory Effects of Various Type Ifn on the Hcv Rna Replication of Hcv
Replicon Cells
Fei, R. et al.
Journal of Hepatology 2007.
46: S168
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100441
32.
61067 OI-LS-376;
WOS-OI-6/8/2007
Novel 4-Azido-2-Deoxy-Nucleoside Analogs Are Potent Inhibitors of
Ns5b-Dependent Hcv Replication
Smith, D. et al.
Journal of Hepatology 2007.
46: S190
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100498
33.
61068 OI-LS-376;
WOS-OI-6/8/2007
Ach-806: a Potent Inhibitor of Hcv Replication With a Novel Mechanism of
Action
Huang, M. et al.
Journal of Hepatology 2007.
46: S221
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100582
34.
61069 OI-LS-376;
WOS-OI-6/8/2007
Inhibition of Hcv Replication by Psi-6130: Mechanism of Biochemical
Activation and Inhibition
Furman, P. et al.
Journal of Hepatology 2007.
46: S224
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100589
35.
61070 OI-LS-376;
WOS-OI-6/8/2007
Effects of Telapravir (Vx950) in a Liver Biopsy Model of Hcv Infection:
Genotype 1 Virions Are Inhibited in Vitro but Other Genotypes Are Less
Responsive
Hibbert, L. and Foster, G.
Journal of Hepatology 2007.
46: S227
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100598
36.
61071 OI-LS-376;
WOS-OI-6/8/2007
Inhibition of Hcv Replication by Psi-6130: Characterization of Activity
in the Hcv Replicon System
Jiang, W. et al.
Journal of Hepatology 2007.
46: S228
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100601
37.
61072 OI-LS-376;
WOS-OI-6/8/2007
R1479, a Novel Nucleoside Analog and Potent Inhibitor of Hcv Replication,
Does Not Affect Ribavirin-Induced Hemolysis and Erythrocyte Fragility in
Vitro
Jiang, W. et al.
Journal of Hepatology 2007.
46: S228
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100602
38.
61073 OI-LS-376;
WOS-OI-6/8/2007
Nim811, a Cyclophilin Inhibitor, and Nm107, an Hcv Polymerase Inhibitor,
Synergistically Inhibits Hcv Replication and Suppresses the Emergence of
Resistance in Vitro
Lin, K. et al.
Journal of Hepatology 2007.
46: S230
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100607
39.
61074 OI-LS-376;
WOS-OI-6/8/2007
Characterization of Pharmacokinetic/Pharmacodynamic Parameters for the
Novel Hcv Polymerase Inhibitor a-848837
Molla, A. et al.
Journal of Hepatology 2007.
46: S234-S235
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100618
40.
61075 OI-LS-376;
WOS-OI-6/8/2007
Short-Term Antiviral Activity and Safety of Ach-806 (Gs-9132), an Ns4a
Antagonist, in Hcv Genotype I Infected Individuals
Pottage, J. et al.
Journal of Hepatology 2007.
46: S294-S295
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100778
41.
61076 OI-LS-376;
WOS-OI-6/8/2007
The Reduction of Both Cyclophilin B and Hcv-Rna by the Cyclophilin
Inhibitor Debio-025 Confirms the Importance of Cyclophilin B for Hcv Replication
in Man
Gallay, R. et al.
Journal of Hepatology 2007.
46: S296
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100782
42.
61077 OI-LS-376;
WOS-OI-6/8/2007
In Vitro Resistance Selection to the Hcv Nucleoside Polymerase Inhibitor
R1479 and to the Protease Inhibitor Vx-950
Mccown, M. et al.
Journal of Hepatology 2007.
46: S297-S298
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100785
43.
61078 OI-LS-376;
WOS-OI-6/8/2007
Hcv Antiviral Activity and Resistance Analysis in Chronically Infected
Chimpanzees Treated With Ns3/4a Protease and Ns513 Polymerase
Inhibitors
Olsen, D. et al.
Journal of Hepatology 2007.
46: S298
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246555100786
44.
61079 OI-LS-376;
WOS-OI-6/8/2007
Il-2-Stimulated Natural Killer Cells Inhibit Hcv Replication: a Novel
Concept to Prevent the Progression of Hcv Reinfection in Liver-Transplant
Recipients Infected With Hcv.
Ohira, M. et al.
American Journal of Transplantation 2007. 7: 328
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246370201129
45.
61080 OI-LS-376;
PUBMED-OI-6/11/2007
NAD(+)-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis:
Novel structure-function relationship and identification of a specific
inhibitor
Srivastava, SK, Dube, D, Kukshal, V, Jha, AK, Hajela, K, and
Ramachandran, R
Proteins 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
46.
61081 OI-LS-376;
PUBMED-OI-6/11/2007
Phenotypic and structural analyses of HCV NS3 protease ARG155 variants:
Sensitivity to telaprevir (VX-950) and interferon alpha
Zhou, Y, Muh, U, Hanzelka, BL, Bartels, DJ, Wei, Y, Rao, BG, Brennan, DL,
Tigges, AM, Swenson, L, Kwong, AD, and Lin, C
J Biol Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
47.
61082 OI-LS-376;
PUBMED-OI-6/11/2007
Synthesis, characterisation and antimicrobial activity of copper(II) and
manganese(II) complexes of coumarin-6,7-dioxyacetic acid (cdoaH(2)) and
4-methylcoumarin-6,7-dioxyacetic acid (4-MecdoaH(2)): X-ray crystal structures
of [Cu(cdoa)(phen)(2)].8.8H(2)O and [Cu(4-Mecdoa)(phen)(2)].13H(2)O
(phen=1,10-phenanthroline)
Creaven, BS, Egan, DA, Karcz, D, Kavanagh, K, McCann, M, Mahon, M, Noble,
A, Thati, B, and Walsh, M
J Inorg Biochem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
48.
61083 OI-LS-376;
PUBMED-OI-6/11/2007
Investigating the Metabolic Capabilities of Mycobacterium tuberculosis
H37Rv Using the in silico Strain iNJ661 and Proposing Alternative Drug
Targets
Jamshidi, N and Palsson, BO
BMC Syst Biol 2007.
1(1): 26
View Data on the NIAID Therapeutics Website
HYPERLINK:
49.
61084 OI-LS-376;
PUBMED-OI-6/11/2007
Design and Synthesis of Classical and Nonclassical
6-Arylthio-2,4-diamino-5-ethylpyrrolo[2,3-d]pyrimidines as
Antifolates
Gangjee, A, Zeng, Y, Talreja, T, McGuire, JJ, Kisliuk, RL, and Queener,
SF
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
50.
61085 OI-LS-376;
PUBMED-OI-6/11/2007
Hepatitis C virus: Virology, diagnosis and management of antiviral
therapy